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1. Introduction 
The release of the lipoprotein 'cleating factor' by 
intravenous heparin was first demonstrated in dogs 
by Hahn [1]. Although equated for many years with 
lipoprotein lipase, the post-heparin lipolytic activity 
(PHLA) of plasma has now been shown to have 
characteristics that are best explained by the release 
of several enzymes [2]. Studies of the effects of in- 
hibitors on rat PHLA after varying degrees of partial 
hepatectomy have strongly suggested the presence of 
two triglyceride lipases (TGL) [3]. Recently aTGL 
purified from human plasma was shown to differ 
from adipose tissue lipoprotein lipase in that (a) there 
was no requirement for an apolipoprotein cofactor 
and (b) high NaC1 concentrations (0.1 M) produced 
activation rather than inhibition [4]. The properties 
of this TGL were similar to those of a lipase activity 
released from dog and rat liver on perfusion with 
heparin-containing solutions [5,6]. These purification 
techniques have now been applied in the study of dog 
PHLA obtained before and after total hepatectomy. 
The properties of the purified preparations are com- 
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pared to those of lipoprotein lipase obtained from dog 
adipose tissue and of the TGL activity in dog liver 
homogenates. 
2. Materials and methods 
Dogs weighing 20--30 kg were fasted for 24 hr, 
anesthetized with pentobarbital nd a siliconized 
cannula was implanted into the external jugular vein. 
Plasma samples were collected before and 10 min 
after injection of heparin (10 U/kg body weight). After 
returning to their standard iet (Purina Dog Chow) 
for 3-7 days, the dogs were again anesthetized and a 
hepatectomy performed. The liver was functionally 
removed without occlusion or interruption of the 
inferior vena cava by use of an Eck fistula. The hepa- 
tic artery and portal vein were ligated and the hepatic 
veins were divided individually. Twenty-four hours 
after hepatectomy, plasma was again collected before 
and 10 min after intravenous heparin injection. 
Acetone-ether powders of dog liver and perirenal 
adipose tissue were prepared as enzyme source for 
TGL activity as previously described [7]. These pow- 
ders were solubilized (50 tzg/ml) in 0.2 M NaC1 con- 
taining 0.005 M Na-barbital, pH 7.4. 
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Dog post-heparin plasma TGL and liver TGL were 
partially purified by ultracentrifugation (D = 1.21) and 
affinity chromatography of the infranatant fraction on 
columns (2.5 × 30 cm) of Sepharose containing cova- 
lently-linked heparin by a modification of the method 
previously described [4]. The infranatant fractions ob- 
tained from the ultracentrifugation step were dialyzed 
versus 0.2 M NaCI, 0.05 M barbital, pH 7.4, and 
diluted 1 : 1 with this buffer prior to application to 
the column. The sample, as obtained from 10 ml of 
original dog plasma, contained 600-700 mg of protein 
in the extract of hepatic acetone-ether powders. After 
the samples were applied, the columns were eluted 
with 400 ml of the starting buffer and a linear NaC1 
gradient was then applied from 0.4 to 1.2 M NaC1 
with 0.05 M sodium veronal, pH 7.4, in all buffers, All 
proteins were determined by the method of Lowry et 
al. 
TGL assays were carried out by the methods pre- 
viously reported [4] using 14C-labeled triolein emul- 
sified in gum arabic. Each vial contained in a final 
volume of 0.5 ml: 0.76 #moles of triolein (0.008/~C/ 
/.tmole); 100/~moles Tris-HCl buffer, pH 8.4, and 
5 mg of bovine albumin as fatty acid acceptor; 20/al 
of post-heparin plasma, liver or adipose tissue extract 
or up to 200/al of column effluents as enzyme source. 
The concentrations of NaC 1 in the final assay mixture 
are indicated (0-1.0 M) in the figures. Total lipids were 
extracted and 14C-labeled free fatty acids were 
isolated by the method of Kelley [8]" Normal dog 
plasma (20/al) was added to all assays of tissue extracts 
or column effluents to provide activator apolipopro- 
teins. 
3.~s~ts  
The effects of increasing concentrations of NaC1 on 
TGL activity in post-heparin plasma nd in acetone- 
ether powder extracts of liver and adipose tissue ob- 
tained from the same dog are presented in fig. 1. TGL 
from the liver extract showed increasing activity with 
increasing salt concentration ver the entire range 
studied and was not inhibited even by NaC 1 concentra- 
tions up to 1 M. That from the adipose tissue was op- 
timally active at 0.05-0.1 M NaC1 and was pro- 
gressively inhibited at higher concentrations. At high 
salt concentrations (0.75-1.0 M) the adipose tissue 
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Fig. 1. Effect of sodium chloride concentrations i  assay me- 
dium on triglyceride lipase activity. The enzyme source was 
an adipose tissue (o - - -D)  or liver (o - - -o )  extract and 
post-heparin plasma (e - - -o )  from a normal fasting (24 hr) 
dog. 
TGL was almost otally inhibited. Post-heparin plasma 
TGL activity from this animal was most active in 
0.15 M NaC1 but was not suppressed in 0.75 or 1.5 M 
NaC 1. The pattern of response to changing NaC 1 con- 
contrations i  clearly very different for the TGL acti- 
vity from the two tissues while that of post-heparin 
plasma TGL, although not identical with either, is 
most similar to that of the liver activity. In fig. 2, the 
effects of NaC 1 concentration  post-heparin plasma 
TGL activity is shown in three dogs before and after 
hepatectomy. In two cases the TGL activity before 
hepatectomy increased with NaC 1 concentration ini- 
tially and then decreased to reach a plateau at 0.5 M 
NaC 1 with no further suppression at 1 M. In the third 
dog the TGL activity was even higher at 1.0 M NaC1. 
The TGL activity in the post-heparin plasma from the 
three intact animals was similar in that a peak or 
shoulder was noted in the activity curve between 0.1 
and 0.25 M NaC 1 and activity was retained at 1.0 M 
NaC1. In contrast, 20 hr after hepatectomy post- 
heparin plasma TGL obtained from all three dogs was 
almost otally inhibited at high NaCI levels, a pattern 
similar to that of the adipose tissue in its response to 
changing ionic strength. 
Post-heparin plasma TGL from each of the three 
animals was then partially purified by ultracentrifuga- 
tion and chromatography on heparin-Sepharose. A 
representative elution pattern from one of these experi- 
ments is shown in fig. 3. In each case, a single 
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Fig. 2. Effect of sodium chloride concentrations in assay me- 
diums on triglyceride lipase activity of post-heparin plasma 
from three dogs obtained before (A-__a, n - - -o ,  
o - - -o )  and after (A--- , , ,  , , - - -=,  o - - -e )  hepatectomy. 
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Fig. 4, Heparin-Sepharose chromatography of solubilized 
acetone-ether powder of dog liver. The chromatography was 
performed with identical techniques and the triglyceride li- 
pase activity (D------G) determined as ih fig. 3. The protein 
concentration i the eluate containing enzyme activity was 
10 to 25 ~g/ml. 
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Fig. 3. Heparin-Sepharose chromatography of the post-heparin 
plasma of a dog before (upper panel) and after (lower panel) 
hepatectomy. The triglyceride lipase activity ( . - - - . )  was 
assayed in the fractions indicated by addition of 200/A 
aliquots to the standard assay system. The increasing NaC1 
concentration (o - - -o )  was produced by a 400 ml gradient- 
forming device. The protein concentration i the eluate 
containing enzyme activity was 2-10/~g/ml. 
peak of  triglyceride lipase activity was eluted between 
0.5 and 0.75 M NaC 1. Identical volumes of post-hepa- 
rin plasma obtained after hepatectomy from each of 
the dogs was subjected to the same purification proce- 
dure using identical conditions. No detectable TGL 
activity was eluted from the heparin-Sepharose 
column (in three separate xperiments) with the post- 
heparin plasma samples obtained after hepatectomy. 
Extracts of the acetone-ether powder prepared from 
the livers of  these dogs were also chromatographed on 
heparin-Sepharose columns. A single peak of TGL 
activity was eluted emerging at NaC 1 concentrations 
identical to those that eluted the enzyme from post- 
heparin plasma. 
Mixing experiments were performed in which plas- 
ma from either intact or hepatectomized dogs was 
added to the post-heparin plasma obtained from each 
type of animal. When these preparations were assayed 
at 0.1 and 1.0 M NaC1 concentrations, results identi- 
cal to those indicated in fig. 2 were obtained. Thus, 
the alterations in character of  the TGL activity in post. 
heparin plasma after hepatectomy are not explained 
by the addition of  an inhibitor or by the loss of  an 
activator substance consequent to the hepatectomy, 
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4. Discussion 
The co-chromatography on heparin-Sepharose 
affinity columns of a TGL obtained from post-heparin 
plasma nd a TGL from extracts of liver is further 
evidence that this organ is one source of TGL in PHLA. 
In fact, the liver may be the only source of this form 
of TGL as indicated by its virtual absence from PHLA 
of hepatectomized animals (figs. 2 and 3). When 
assayed at lower NaC1 concentrations (0.1 M) PHLA 
in hepatectomized animals was about one-third that 
seen in the intact animal. However, affinity column 
chromatography showed no detectable activity 
corresponding to that isolated from post-heparin plas- 
ma of intact animals. Although less total activity was 
loaded onto the column, the sensitivity of the method 
is such that as little as 5-10% of this activity would 
have been detected if it had had the properties of the 
enzyme found in the animal with a functional 
liver. The PHLA remaining after hepatectomy was, in 
its response to changing ionic strengths, identical to 
adipose tissue lipoprotein lipase and other peripheral 
tissue lipoprotein lipases [6]. 
It should be noted that with the procedure used 
in the present studies, designed for isolation of the 
hepatic enzyme other forms of post-heparin TGL may 
not be isolated. Techniques recently developed in the 
study of swine have allowed purification of a second 
enzyme from PHLA which has the characteristics of 
lipoprotein lipase purified from adipose tissue [91. 
The relative quantities of the two enzymes in PHLA 
probably varies considerably from animal to animal, 
as indicated by the variations in the relative TGL 
activity noted in the dogs prior to hepatectomy when 
assayed at 0. I M (optin~m for lipoprotein lipase) or 
1.0 M NaCI. In other studies, using non-fasting dogs, 
the relative activity at the lower salt concentrations 
has been 2- or 3-fold greater than that obtained when 
assayed at high ionic strength. This is consistent with 
the known effects of fasting on lipoprotein lipase 
levels in adipose tissue [101. Fasting actually in- 
creases lipoprotein lipase in the heart and certain 
other tissues [11 ]. Thus, it may be that adipose 
tissue is quantitaVely a more important contributor 
to PHLA than other peripheral tissues. The physiolo- 
gical role of the liver enzyme characterized in the 
present studies remains unknown. Studies of the rela- 
tive amounts of this enzyme and of the 'extra-hepatic 
enzymes' released by heparin may be helpful in 
elucidating disorders of lipoprotein metabolism. 
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